MarketCap
Facebook
X
TelegramQuarterly report 2024-Q3
added 11-07-2024
Country |
 USA |
IPO year |
2020 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
90.2 M |
Market Cap[1] |
$ 857 M |
EBITDA (LTM) |
$ -67.4 M |
P/E (LTM) |
- |
P/S (LTM) |
6.34 |
EPS (LTM) |
-0.71 |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
- | 2.43 % | $ 254 M | Nasdaq Global Select Market |  Germany |
 |
Arbutus Biopharma Corporation
ABUS
|
$ 4.5 | 0.45 % | $ 862 M | Nasdaq Global Select Market |  Canada |
 |
ADC Therapeutics SA
ADCT
|
$ 3.83 | 1.32 % | $ 105 M | NYSE |  Schweiz |
 |
Agenus
AGEN
|
$ 3.64 | 9.31 % | $ 108 M | Nasdaq Capital Market | USA |
 |
Agios Pharmaceuticals
AGIO
|
$ 35.08 | -0.36 % | $ 2.03 B | Nasdaq Global Select Market,SPB | USA |
 |
Akebia Therapeutics
AKBA
|
$ 1.39 | 0.36 % | $ 357 M | Nasdaq Global Market | USA |
 |
Akari Therapeutics, Plc
AKTX
|
$ 3.95 | -11.63 % | $ 266 B | Nasdaq Capital Market |  Britain |
 |
I-Mab
IMAB
|
- | - | $ 866 M | Nasdaq Global Select Market |  China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
- | - | $ 40.3 B | Nasdaq Global Select Market | USA |
 |
Genfit SA
GNFT
|
- | 2.54 % | $ 160 B | Nasdaq Global Select Market |  France |
 |
Aldeyra Therapeutics
ALDX
|
$ 1.57 | -5.42 % | $ 94.3 M | Nasdaq Global Select Market | USA |
 |
Aligos Therapeutics
ALGS
|
$ 8.08 | 1.38 % | $ 79.9 M | Nasdaq Global Select Market | USA |
 |
Biophytis SA
BPTS
|
- | -13.47 % | $ 169 M | Nasdaq Capital Market | France |
 |
Alnylam Pharmaceuticals
ALNY
|
$ 331.14 | 3.85 % | $ 43.4 B | Nasdaq Global Select Market,SPB | USA |
 |
Altimmune
ALT
|
$ 3.4 | 1.8 % | $ 300 M | Nasdaq Global Market | USA |
 |
ALX Oncology Holdings
ALXO
|
$ 1.99 | 0.81 % | $ 107 M | Nasdaq Global Select Market,SPB | USA |
 |
Amgen
AMGN
|
$ 344.03 | -1.12 % | $ 185 B | Nasdaq Global Select Market,SPB | USA |
 |
Midatech Pharma plc
MTP
|
- | -18.52 % | $ 27.3 M | Nasdaq Global Select Market | Britain |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
- | -1.52 % | $ 24.7 M | Nasdaq Capital Market | USA |
 |
Amneal Pharmaceuticals
AMRX
|
$ 12.27 | -1.68 % | $ 3.85 B | NYSE | USA |
 |
Anika Therapeutics
ANIK
|
$ 14.99 | 1.28 % | $ 220 M | Nasdaq Global Select Market,SPB | USA |
 |
Acorda Therapeutics
ACOR
|
- | -24.86 % | $ 820 K | Nasdaq Global Select Market | USA |
 |
ANI Pharmaceuticals
ANIP
|
$ 73.8 | -0.55 % | $ 1.43 B | Nasdaq Global Market,SPB | USA |
 |
Annexon
ANNX
|
$ 5.56 | 1.0 % | $ 862 M | Nasdaq Global Select Market | USA |
 |
Annovis Bio
ANVS
|
$ 2.56 | 12.28 % | $ 52.6 M | NYSE American | USA |
 |
Adverum Biotechnologies
ADVM
|
- | - | $ 86.2 M | Nasdaq Global Market | USA |
 |
Advaxis
ADXS
|
- | -9.65 % | $ 45.9 M | Nasdaq Capital Market | USA |
 |
Aptorum Group Limited
APM
|
$ 0.88 | -5.16 % | $ 4.8 M | Nasdaq Global Select Market | China |
 |
Applied Molecular Transport
AMTI
|
- | - | $ 10.1 M | Nasdaq Global Select Market,SPB | USA |
 |
Aprea Therapeutics
APRE
|
$ 0.7 | -1.87 % | $ 4.58 M | Nasdaq Global Select Market,SPB | USA |
 |
Aquestive Therapeutics
AQST
|
$ 4.12 | -0.24 % | $ 441 M | Nasdaq Global Market | USA |
 |
Aeterna Zentaris
AEZS
|
- | 5.93 % | $ 314 M | Nasdaq Capital Market | Canada |
 |
AgeX Therapeutics
AGE
|
- | -10.17 % | $ 12.2 K | NYSE American | USA |
 |
AIkido Pharma
AIKI
|
- | 1.93 % | $ 17.4 M | Nasdaq Capital Market | USA |
 |
Arcturus Therapeutics Holdings
ARCT
|
$ 8.14 | 1.31 % | $ 223 M | Nasdaq Global Market,SPB |  Israel |
 |
Aeglea BioTherapeutics
AGLE
|
- | - | $ 1.01 B | Nasdaq Global Market | USA |
 |
Ardelyx
ARDX
|
$ 5.99 | 0.84 % | $ 1.44 B | Nasdaq Global Market | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
- | - | $ 26.5 M | Nasdaq Global Select Market | USA |
 |
Akero Therapeutics
AKRO
|
- | - | $ 3.67 B | Nasdaq Global Select Market,SPB | USA |
 |
Akouos
AKUS
|
- | 0.23 % | $ 488 M | Nasdaq Global Select Market | USA |
 |
argenx SE
ARGX
|
$ 749.99 | 0.48 % | $ 25 B | Nasdaq Global Select Market |  Niderland |
 |
Институт стволовых клеток человека
ISKJ
|
- | - | - | MOEX |  Russia |
 |
Arcutis Biotherapeutics
ARQT
|
$ 24.06 | 1.82 % | $ 3.06 B | Nasdaq Global Select Market,SPB | USA |
 |
Arvinas
ARVN
|
$ 10.87 | 0.14 % | $ 771 M | Nasdaq Global Select Market,SPB | USA |
 |
Arrowhead Pharmaceuticals
ARWR
|
$ 60.28 | -1.23 % | $ 8.06 B | Nasdaq Global Select Market,SPB | USA |
 |
Allena Pharmaceuticals
ALNA
|
- | 3.16 % | $ 1.9 M | Nasdaq Global Select Market | USA |
 |
Assembly Biosciences
ASMB
|
$ 29.51 | 1.72 % | $ 331 M | Nasdaq Global Select Market,SPB | USA |
 |
Alpine Immune Sciences
ALPN
|
- | - | $ 2.17 B | Nasdaq Global Market | USA |
 |
Aileron Therapeutics
ALRN
|
- | 10.36 % | $ 9.8 M | Nasdaq Global Select Market | USA |
 |
Alterity Therapeutics Limited
ATHE
|
$ 3.62 | 1.82 % | $ 8.71 B | Nasdaq Capital Market |  Australia |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.